September 28,2007
Sen. Grassley urges FDA to implement recommendations of Inspector General for human subjects in clinical trials
WASHINGTON — Sen. Chuck Grassley is calling on the Food and Drug Administration to implement recommendations stemming from an independent review of the agency’s oversight of clinical trials involving human subjects.
“We’re all in debt to the individuals who volunteer for the clinical trials that advance medicine and lead to lifesaving cures. The Food and Drug Administration needs to make sure these human subjects are treated properly and fully informed,” Grassley said.
Grassley made his appeal in a letter to the FDA Commissioner. The text is below. The report of the Inspector General for the Department of Health and Human Services containing the recommendations is posted at http://finance.senate.gov, along with this news release.
###
Next Article Previous Article
Recent News
- Wyden Blasts Trump Weaponization of IRS Against Progressive Speech
- Wyden, Warren, Sanders, Warnock Probe Medicaid Contractors on Faulty Eligibility and Enrollment Systems
- Trumpcare is Already Wreaking Havoc on American Health Care
- Wyden, Finance Democrats Urge Crapo to Investigate Kennedy on Anti-Vax Actions and Conflicts of Interests
- Wyden, Paul, Schumer, and Kaine Introduce Bipartisan Legislation to Repeal Global Tariffs and Restore Congressional Authority Over Trade